MSB 3.76% $1.03 mesoblast limited

Growing doubt on COVID-19 Application

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    It’s time to start a specific thread on whether the COVID-19 application will proceed.

    I think there is enough evidence to suggest the COVID-19 application will not be a goer. The Novartis delay is quite inexplicable given the global emergency.

    Sure, there might be some reason for Novartis not proceeding quickly. But absence any clarifying statement it is not clear what that could be. The mystery deepens because of the confidant statement three months or so ago that the announcement would be in a few weeks.

    If Novartis walk away, what will that mean for the Covid-19 application?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.08 $1.09 $1.03 $7.869M 7.571M

Buyers (Bids)

No. Vol. Price($)
1 16411 $1.03
 

Sellers (Offers)

Price($) Vol. No.
$1.03 3952 2
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
$1.03
  Change
-0.040 ( 3.65 %)
Open High Low Volume
$1.07 $1.08 $1.03 1907057
Last updated 15.59pm 06/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.